Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Shares Issued: 2021-2025

Historic Shares Issued for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $4.0 million.

  • Cellebrite DI's Shares Issued fell 14.37% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 61.91%. This contributed to the annual value of $17.3 million for FY2024, which is 9.81% down from last year.
  • Per Cellebrite DI's latest filing, its Shares Issued stood at $4.0 million for Q3 2025, which was down 68.65% from $12.6 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Shares Issued high stood at $12.6 million for Q2 2025, and its period low was $944,000 during Q4 2021.
  • Its 3-year average for Shares Issued is $5.0 million, with a median of $4.3 million in 2024.
  • As far as peak fluctuations go, Cellebrite DI's Shares Issued skyrocketed by 463.71% in 2022, and later crashed by 49.44% in 2024.
  • Cellebrite DI's Shares Issued (Quarterly) stood at $944,000 in 2021, then surged by 40.57% to $1.3 million in 2022, then skyrocketed by 188.39% to $3.8 million in 2023, then spiked by 50.41% to $5.8 million in 2024, then declined by 14.37% to $4.0 million in 2025.
  • Its Shares Issued stands at $4.0 million for Q3 2025, versus $12.6 million for Q2 2025 and $2.5 million for Q1 2025.